Titanium ion (Ti ion)

Titanium ion refers to the cationic species of titanium, most commonly the tetravalent Ti4+, which are generated in vivo through the corrosion and wear of titanium-based medical and dental implants (PubChem CID 104755). While titanium is renowned for its biocompatibility due to its stable oxide layer, the accumulation of free ions can trigger localized adverse tissue reactions, including chronic inflammation and aseptic loosening of prostheses (PubMed: 25613713). These ions exhibit a high affinity for iron-binding proteins like transferrin, which serves as a primary vehicle for their transport in the bloodstream and potential systemic distribution (PubMed: 11460565). Although titanium ions are not traditional therapeutic targets, they have been investigated as the pharmacologically active centers of experimental organometallic anti-cancer drugs, such as titanocene dichloride, which demonstrated cytotoxic activity by interacting with DNA (PubMed: 15563581). In clinical practice, monitoring titanium ion concentrations in serum or synovial fluid is often used to assess the integrity of orthopedic implants and the risk of implant-related complications (StatPearls: Orthopedic Implant Failure).

Other names

Titanium(4+) ionTi4+Titanium(IV) ionTitanium(3+) ionTi3+

Titanium ions released from implants activate the NLRP3 inflammasome in macrophages, leading to the secretion of pro-inflammatory cytokines like IL-1beta (PubMed: 25613713). They also bind to transferrin, competing with iron for transport (PubMed: 11460565). In anti-cancer complexes, the titanium center interacts with DNA to inhibit replication (PubMed: 15563581).